EMA backs renewing conditional marketing approval for remdesivir in COVID-19 patients

By Syndicated Content May 21, 2021 | 7:53 AM

(Reuters) – Europe’s medicines regulator on Friday recommended to renew the conditional marketing authorization for Gilead Sciences’ remdesivir to treat COVID-19.

(Reporting by Vishwadha Chander in Bengaluru; Editing by Anil D’Silva)